{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:53:18Z","timestamp":1790171598172,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Peptides"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.regpep.2007.03.008","type":"journal-article","created":{"date-parts":[[2007,4,12]],"date-time":"2007-04-12T07:12:59Z","timestamp":1176361979000},"page":"97-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["DPP-4 inhibition improves glucose tolerance and increases insulin and GLP-1 responses to gastric glucose in association with normalized islet topography in mice with \u03b2-cell-specific overexpression of human islet amyloid polypeptide"],"prefix":"10.1016","volume":"143","author":[{"given":"Bo","family":"Ahr\u00e9n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria S\u00f6rhede","family":"Winzell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Wierup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Sundler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Burkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.regpep.2007.03.008_bib1","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1517\/13543784.13.9.1091","article-title":"Inhibitors of dipeptidyl peptidase IV: a novel approach to prevention and treatment of type 2 diabetes","volume":"13","author":"Deacon","year":"2004","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.regpep.2007.03.008_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1573408052952667","article-title":"Inhibition of dipeptidyl peptidase-4 (DPP-4) \u2014 a novel approach to treat type 2 diabetes","volume":"1","author":"Ahr\u00e9n","year":"2005","journal-title":"Curr Enzyme Inhib"},{"key":"10.1016\/j.regpep.2007.03.008_bib3","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1742-1241.2006.01178.x","article-title":"DPP-4 inhibitors and their potential role in the management of type 2 diabetes","volume":"60","author":"Barnett","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.regpep.2007.03.008_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(00)00600-2","article-title":"Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice","volume":"404","author":"Ahr\u00e9n","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.regpep.2007.03.008_bib5","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s001250051445","article-title":"Inhibition of dipeptidyl peptidase IV with NVP DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats","volume":"42","author":"Balkan","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.regpep.2007.03.008_bib6","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1530\/eje.0.1460717","article-title":"Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice","volume":"146","author":"Kvist Reimer","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.regpep.2007.03.008_bib7","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2337\/diab.47.8.1253","article-title":"Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide","volume":"47","author":"Pedersen","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2007.03.008_bib8","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.2337\/diacare.27.12.2874","article-title":"Twelve-and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes","volume":"27","author":"Ahr\u00e9n","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.regpep.2007.03.008_bib9","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1210\/jc.2003-031907","article-title":"Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels and reduces glucagon levels in type 2 diabetes","volume":"89","author":"Ahr\u00e9n","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.regpep.2007.03.008_bib10","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1007\/s00125-006-0416-z","article-title":"Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus","volume":"49","author":"Raz","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.regpep.2007.03.008_bib11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejphar.2005.08.019","article-title":"Beta-cell expression of a dominant-negative HNF-1\u03b1 compromises the ability of inhibition of dipeptidyl peptidase-4 to elicit a long-term augmentation of insulin secretion in mice","volume":"521","author":"Ahr\u00e9n","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.regpep.2007.03.008_bib12","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1007\/s001250051079","article-title":"Transgenic overexpression of human islet amyloid polypeptide inhibits insulin secretion and glucose elimination after gastric glucose gavage in mice","volume":"41","author":"Ahr\u00e9n","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.regpep.2007.03.008_bib13","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/diabetes.52.2.372","article-title":"Increased dietary fat promotes islet amyloid formation and \u03b2-cell secretory dysfunction in a transgenic mouse model of islet amyloid","volume":"52","author":"Hull","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2007.03.008_bib14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0014-2999(91)90239-M","article-title":"Effects of amidated rat islet amyloid polypeptide on glucose-stimulated insulin secretion in vivo and in vitro in rats","volume":"192","author":"Ar'Rajab","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.regpep.2007.03.008_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0167-0115(93)90411-Z","article-title":"Amylin inhibits glucose-induced insulin secretion in a dose-dependent manner. Study in the perfused rat pancreas","volume":"43","author":"Degano","year":"1993","journal-title":"Regul Pept"},{"key":"10.1016\/j.regpep.2007.03.008_bib16","first-page":"E300","article-title":"Islet amyloid polypeptide inhibits insulin secretion in conscious rats","volume":"267","author":"F\u00fcrnsinn","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.regpep.2007.03.008_bib17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJM200008103430607","article-title":"Mechanisms of disease: islet amyloid and type 2 diabetes mellitus","volume":"343","author":"H\u00f6ppener","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.regpep.2007.03.008_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2337\/db06-0734","article-title":"Human islet amyloid polypeptide oligomers disrupt cell coupling, induce apoptosis, and impair insulin secretion in isolated human islets","volume":"56","author":"Ritzel","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2007.03.008_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0167-0115(02)00298-7","article-title":"Postnatally disturbed pancreatic islet cell distribution in human islet amyloid polypeptide transgenic mice","volume":"113","author":"Wong","year":"2003","journal-title":"Regul Pept"},{"key":"10.1016\/j.regpep.2007.03.008_bib20","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1021\/jm030091l","article-title":"1-[[(3-hydroxy-1-adamantyl) amino] acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties","volume":"46","author":"Villhauer","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.regpep.2007.03.008_bib21","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1073\/pnas.93.8.3492","article-title":"Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide","volume":"93","author":"Verchere","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.regpep.2007.03.008_bib22","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.2337\/diabetes.49.12.2056","article-title":"\u03b2-Cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes","volume":"49","author":"Andrikopoulos","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2007.03.008_bib23","first-page":"E956","article-title":"Reduced GLP-1 and insulin responses and glucose intolerance after gastric glucose in GRP receptor-deleted mice","volume":"279","author":"Persson","year":"2000","journal-title":"Am J Physiol"},{"key":"10.1016\/j.regpep.2007.03.008_bib24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/002215540405200204","article-title":"Cocaine- and amphetamine-regulated transcript (CART) is expressed in several islet cell types during rat development","volume":"52","author":"Wierup","year":"2004","journal-title":"J Histochem Cytochem"},{"issue":"suppl 3","key":"10.1016\/j.regpep.2007.03.008_bib25","first-page":"S215","article-title":"The high-fat fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes","volume":"53","author":"S\u00f6rhede Winzell","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2007.03.008_bib26","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1124\/jpet.105.087064","article-title":"Acute and chronic effects of the incretin enhancer vildagliptin in insulin-resistant rats","volume":"315","author":"Burkey","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"suppl 1","key":"10.1016\/j.regpep.2007.03.008_bib27","first-page":"A350","article-title":"Acute DPP IV inhibition minimizes glucose and insulin responses to a glucose challenge in a diabetic mouse","volume":"52","author":"Mika","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2007.03.008_bib28","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1210\/endo.142.12.8592","article-title":"\u03b2-Cell-targeted expression of a dominant-negative hepatocyte nuclear factor-1\u03b1 induces a maturity-onset diabetes of the young (MODY)3-like phenotype in transgenic mice","volume":"142","author":"Hagenfeldt-Johansson","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.regpep.2007.03.008_bib29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0303-7207(95)03646-O","article-title":"Differential expression of islet amyloid polypeptide (amylin) and insulin in experimental diabetes in rodents","volume":"114","author":"Mulder","year":"1995","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.regpep.2007.03.008_bib30","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1677\/joe.0.1520495","article-title":"Differential effect of insulin treatment on islet amyloid polypeptide (amylin) and insulin gene expression in streptozotocin-induced diabetes in rats","volume":"152","author":"Mulder","year":"1997","journal-title":"J Endocrinol"},{"key":"10.1016\/j.regpep.2007.03.008_bib31","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1210\/jc.2004-2460","article-title":"Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes","volume":"90","author":"Mari","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.regpep.2007.03.008_bib32","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1530\/eje.0.1460863","article-title":"The short half-life of glucagon-like peptide-1 in plasma does not reflect its long-lasting beneficial effects","volume":"146","author":"Hui","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.regpep.2007.03.008_bib33","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.2337\/diabetes.48.12.2270","article-title":"Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats","volume":"48","author":"Xu","year":"1999","journal-title":"Diabetes"}],"container-title":["Regulatory Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011507000870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011507000870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T15:16:23Z","timestamp":1759072583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167011507000870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":33,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0167011507000870"],"URL":"https:\/\/doi.org\/10.1016\/j.regpep.2007.03.008","relation":{},"ISSN":["0167-0115"],"issn-type":[{"value":"0167-0115","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DPP-4 inhibition improves glucose tolerance and increases insulin and GLP-1 responses to gastric glucose in association with normalized islet topography in mice with \u03b2-cell-specific overexpression of human islet amyloid polypeptide","name":"articletitle","label":"Article Title"},{"value":"Regulatory Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.regpep.2007.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}